Increased epithelial permeability in pulmonary fibrosis in relation to disease progression.
Goh
N S L
NS
Royal Brompton Hospital and National Heart and Lung Institute, London, UK.
Desai
S R
SR
Anagnostopoulos
C
C
Hansell
D M
DM
Hoyles
R K
RK
Sato
H
H
Denton
C P
CP
Black
C M
CM
du Bois
R M
RM
Wells
A U
AU
D000328:Adult; D000368:Aged; D015331:Cohort Studies; D018450:Disease Progression; D004848:Epithelium / Q000473:pathology*; D005260:Female; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D010539:Permeability; D011379:Prognosis; D016016:Proportional Hazards Models; D011658:Pulmonary Fibrosis / Q000473:pathology*; D019275:Radiopharmaceuticals / Q000494:pharmacology; D016284:Technetium Tc 99m Pentetate / Q000494:pharmacology*; D016896:Treatment Outcome
D019275:Radiopharmaceuticals; D016284:Technetium Tc 99m Pentetate